Omalizumab

Cat. No.: PI242138074

Description: Omalizumab belongs to the group of monoclonal antibodies. The active ingredient selectively binds to an immunoglobulin that mediates allergic reactions. It is used for the treatment of severe bronchial asthma and chronic, spontaneous urticaria.

Product Details

CAS	242138-07-4
Product Status	Development
Uses	Drugs for obstructive airway diseases
Molecular Size	Large
Controlled Substance	No

* Our products are for research use only.

Get in Touch

We’re glad to help you with your products and services demands. For any inquiry, question or recommendation, please send an email to or fill out the following form.

Name *

Phone

Email *

Address *

Products & Service of Interest *

Project Description

Verification Code *

For product and service inquiries, please use our online system or send an email to .